Managing Cognitive Dysfunction through the Continuum of Alzheimerʼs Disease

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

(2013) Parminder Raina et al.   ANNALS OF INTERNAL MEDICINE

Alzheimer's disease: clinical trials and drug development

(2010) Francesca Mangialasche et al.   LANCET NEUROLOGY

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

(2009) Å. K. Wallin et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Mild Alzheimer’s disease: A «Position Paper»

(2009) J. Delrieu et al.   Journal of Nutrition Health & Aging

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

(2009) Dag Aarsland et al.   LANCET NEUROLOGY

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine

(2008) Renato Scacchi et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Anton Porsteinsson et al.   Current Alzheimer Research

SPECT-Identified Neuroanatomical Predictor of the Cognitive Effects of Donepezil Treatment in Patients with Alzheimer’s Disease

(2008) Jin Hongo et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Safety and efficacy of galantamine in subjects with mild cognitive impairment

(2008) B. Winblad et al.   NEUROLOGY

Prediction of response to donepezil in Alzheimer??s disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion

(2008) Hidekazu Kanetaka et al.   NUCLEAR MEDICINE COMMUNICATIONS